Statement of Organization, Functions, and Delegations of Authority, 62559-62560 [2010-25221]
Download as PDF
<![CDATA[
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices
distribution of investigational drugs for
the treatment and prevention of TB by
CIOs/Scientific Resources/Drug Service;
(6) assesses the need for and conducts
clinical and field trials of more specific
and rapid tests to diagnose active TB
and latent TB infection and to identify
drug-resistant TB in collaboration with
the Laboratory Branch; (7) collaborates
with and provides consultation and
technical assistance to national and
international organizations on the
design and conduct of clinical trials and
research needs; (8) conducts,
participates in, and collaborates with
other DTBE units in research on
clinical, epidemiologic, immunologic
and genetic aspects of TB prevention
and control; (9) collaborates in contact
investigation research with other
branches and local programmatic areas;
(10) conducts multidisciplinary studies
(including the analysis of behavioral,
economic, and epidemiologic factors) of
health care systems to assess the cost,
effectiveness, and impact of public
health policies, programs, and practices
on TB outcomes to further the goal of
TB elimination in the U.S., and targets
these studies toward various
populations at high risk for TB,
including persons from high TB
prevalent countries, homeless persons,
HIV-infected persons, residents of
correctional facilities, substance
abusers, and health care workers; (11)
provides consultation and training to
local, state, national, and international
organizations, and to TB program field
staff, on design and conduct of clinical
trials, TB therapeutics and diagnostics,
health care systems research needs,
decision and economic analyses,
evaluation techniques, qualitative
research methods, and research on TB
transmission; (12) has responsibility for
divisional engagement in preparing for
and participating in trials of new TB
vaccines; (13) reports study results to
public health practitioners through
direct communication, articles in
scientific journals and CDC
publications, and oral and poster
presentations at national and
international scientific meetings; (14)
provides input into statements and
guidelines issued by the CDC, the
ACET, and professional organizations;
and (15) presents research issues and
findings to ACET and at national and
international scientific meetings.
Delete items (2), (3), (4), and (6) of the
functional statement for the
International Research and Programs
Branch (CVJEI1D), and insert the
following: (2) Coordinates the
assessment of immigration and its
impact on TB patterns in the U.S. and
VerDate Mar<15>2010
17:43 Oct 08, 2010
Jkt 223001
assists with the evaluation of overseas
TB screening procedures for immigrants
and refugees; (3) conducts and
coordinates operational research and
demonstration projects to improve both
the overseas screening for TB of
immigrants and refugees and the
domestic follow-up of those entering
with suspected TB (in collaboration
with other CIOs); (4) promotes the
improved recognition and management
of TB among the foreign-born through
epidemiological analyses of national TB
surveillance data and special studies on
the U.S./Mexico border and in countries
contributing to foreign-born TB cases in
the U.S.; (6) collaborates with the nation
of Botswana, WHO, the World Bank,
IUATLD, USAID, and others, to conduct
investigations into the diagnosis,
management, and prevention of TB in
persons with and without HIV infection.
Delete in its entirety the title and
function statement for the
Mycobacteriology Laboratory Branch
(CVJEJ), and insert the following:
Laboratory Branch (CVJEJ). (1) Serves
as the national reference laboratory in
support of the mission of DTBE,
fulfilling public health function in
leadership, clinical and consultative
service, and research; (2) provides
laboratory support for epidemic
investigations, surveillance activities,
and special studies of TB, in
collaboration of other branches; (3)
administers contracts to provide
Mycobacterium tuberculosis
genotyping, maintains a national
database of genotypes, and conducts
operational research to implement
genotyping; (4) develops and evaluates
new methods to subtype M tuberculosis
for epidemiologic studies; (5) serves as
primary CDC focus for diagnostic
laboratory services for TB; (6)
administers grants and cooperative
agreements with states and others to
upgrade laboratory activities and
provide special services; (7) provides
reference diagnostic services,
consultation, technical assistance, and
training to state, federal, and municipal
public health laboratories; (8) provides
laboratory support, reference services,
assessment, consultation, and training
for CDC’s international TB activities; (9)
develops, evaluates, or improves
conventional and molecular methods for
the detection, classification,
identification, characterization, and
susceptibility testing of M tuberculosis;
(10) conducts studies to define the role
of bacterial virulence factors, host
factors, and pathogenic and
immunologic mechanisms in disease
processes and protective immunity in
mycobacteria, and develops, evaluates,
and improves immunologic methods for
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
62559
the diagnosis and prevention of TB; (11)
develops tissue culture and animal
models of TB and conducts studies on
chemotherapy, immunotherapy,
pathogenesis, pathology, and vaccines
for TB; (12) prepares manuscripts for
publication in scientific journals; (13)
presents findings at national and
international scientific meetings; (14)
supervises and trains fellows in
temporary or multi-year educationallybased programs in endeavors related to
the mission of the branch; and (15)
presents laboratory issues to ACET and
at national and international scientific
meetings.
Dated: September 27, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–25427 Filed 10–8–10; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
Statement of Organization, Functions,
and Delegations of Authority
Part J (Agency for Toxic Substances
and Disease Registry) of the Statement
of Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (50 FR 25129–25130, dated
June 17, 1985, as amended most
recently at 73 FR 20293, dated April 15,
2008) is amended to reflect the
reorganization of the Agency for Toxic
Substances and Disease Registry.
Section J–B, Organization and
Functions, is hereby amended as
follows: After the title and function
statement for the Office of Policy,
Planning, and Evaluation (JAA3), Office
of the Director (JAA), Office of the
Administrator (JA), Agency for Toxic
Substances and Disease Registry (J),
insert the following:
Office of Communication (JAA7). The
Office of Communication (OC): (1)
Serves as the principal advisor to the
Agency Assistant Administrator and
divisions on communication and
marketing science, research, practice,
and public affairs; (2) leads agency
strategic planning for communication
and marketing science and public affairs
programs and projects; (3) analyzes
context, situation, and environment to
inform agency-wide communication and
marketing programs and projects; (4)
ensures use of scientifically sound
research for marketing and
communication programs and projects;
E:\FR\FM\12OCN1.SGM
12OCN1
62560
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices
(5) ensures accurate, accessible, timely,
and effective translation of science for
use by multiple audiences; (6) leads
identification and implementation of
information dissemination channels; (7)
provides communication and marketing
project management expertise; (8)
collaborates with external organizations
and the news, public service, and
entertainment and other media to
ensure that scientific findings and their
implications for public health reach the
intended audiences; (9) collaborates
closely with divisions to produce
materials tailored to meet the
requirements of news and other media
channels, including press releases,
letters to the editor, public service
announcements, television
programming, video news releases, and
other electronic and printed materials;
(10) coordinates the development and
maintenance of accessible public
information through the Internet, social
media and other applicable channels;
(11) supervises and manages a
comprehensive records management
activity in accordance with National
Archives and Records Administration
standards and CERCLA legislative
requirements; (12) provides training and
technical assistance in the areas of
health communication, risk
communication, social marketing, and
public affairs; (13) provides editorial
services, including writing, editing, and
technical editing; (14) supervises and
manages OC activities, programs, and
staff; (15) serves as liaison to internal
and external groups to advance the
agency’s mission; (16) collaborates with
the CDC Office of the Associate Director
for Communication on media relations,
electronic communication, health media
production, and brand management
activities; and (17) collaborates with
CDC Centers/Institute/Offices in the
development of marketing
communications targeted to populations
that would benefit from a crossfunctional approach.
Dated: September 27, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–25221 Filed 10–8–10; 8:45 am]
srobinson on DSKHWCL6B1PROD with NOTICES
BILLING CODE 4160–70–M
VerDate Mar<15>2010
17:43 Oct 08, 2010
Jkt 223001
DEPARTMENT OF HOMELAND
SECURITY
United States Immigration and
Customs Enforcement
Agency Information Collection
Activities: Extension of a Currently
Approved Information Collection;
Comment Request
30-Day Notice of Information
Collection for Review; Application for
Stay of Deportation or Removal, Form
I–246, OMB No. 1653–0021.
ACTION:
The Department of Homeland
Security, U.S. Immigration and Customs
Enforcement (ICE), is submitting the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. The Information Collection was
previously published in the Federal
Register on July 15, 2010, Vol. 75, No.
135, 41214, allowing for a 60-day public
comment period. ICE received no
comments on this Information
Collection from the public during this
60-day period. The purpose of this
notice is to allow an additional 30 days
for public comments. Comments are
encouraged and will be accepted for
thirty days until November 12, 2010.
Written comments and suggestions
from the public and affected agencies
regarding items contained in this notice
and especially with regard to the
estimated public burden and associated
response time should be directed to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the OMB Desk Officer for U.S.
Immigration and Customs Enforcement,
Department of Homeland Security, and
sent via electronic mail to
oira_submission@omb.eop.gov or faxed
to (202) 395–5806. Written comments
and suggestions from the public and
affected agencies concerning the
proposed collection of information
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
Information Collection.
(2) Title of the Form/Collection:
Application for Stay of Deportation or
Removal.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: I–246; U.S.
Immigration and Customs Enforcement.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individual or
Households, Business or other nonprofit. The information collected on the
Form I–246 is necessary for U.S.
Immigration and Customs Enforcement
(ICE) to make a determination that the
eligibility requirements for a request for
a stay of deportation or removal are met
by the applicant.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 10,000 responses at 30 minutes
(.50 hours) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 5,000 annual burden hours.
Requests for a copy of the proposed
information collection instrument, with
instructions; or inquiries for additional
information regarding this Information
Collection should be requested
via e-mail to: forms.ice@dhs.gov with
‘‘ICE Form I–246’’ in the subject line.
Dated: October 5, 2010.
Joseph M. Gerhart,
Chief, Records Management Branch, U.S.
Immigration and Customs Enforcement,
Department of Homeland Security.
[FR Doc. 2010–25555 Filed 10–8–10; 8:45 am]
BILLING CODE 9111–28–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0618]
Exemption and Equivalent
Arrangements Under the International
Convention on Load Lines, 1966, as
Modified by the Protocol of 1988
AGENCY:
E:\FR\FM\12OCN1.SGM
Coast Guard, DHS.
12OCN1
]]>Agencies
[Federal Register Volume 75, Number 196 (Tuesday, October 12, 2010)]
[Notices]
[Pages 62559-62560]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-25221]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
Statement of Organization, Functions, and Delegations of
Authority
Part J (Agency for Toxic Substances and Disease Registry) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (50 FR 25129-25130, dated
June 17, 1985, as amended most recently at 73 FR 20293, dated April 15,
2008) is amended to reflect the reorganization of the Agency for Toxic
Substances and Disease Registry.
Section J-B, Organization and Functions, is hereby amended as
follows: After the title and function statement for the Office of
Policy, Planning, and Evaluation (JAA3), Office of the Director (JAA),
Office of the Administrator (JA), Agency for Toxic Substances and
Disease Registry (J), insert the following:
Office of Communication (JAA7). The Office of Communication (OC):
(1) Serves as the principal advisor to the Agency Assistant
Administrator and divisions on communication and marketing science,
research, practice, and public affairs; (2) leads agency strategic
planning for communication and marketing science and public affairs
programs and projects; (3) analyzes context, situation, and environment
to inform agency-wide communication and marketing programs and
projects; (4) ensures use of scientifically sound research for
marketing and communication programs and projects;
[[Page 62560]]
(5) ensures accurate, accessible, timely, and effective translation of
science for use by multiple audiences; (6) leads identification and
implementation of information dissemination channels; (7) provides
communication and marketing project management expertise; (8)
collaborates with external organizations and the news, public service,
and entertainment and other media to ensure that scientific findings
and their implications for public health reach the intended audiences;
(9) collaborates closely with divisions to produce materials tailored
to meet the requirements of news and other media channels, including
press releases, letters to the editor, public service announcements,
television programming, video news releases, and other electronic and
printed materials; (10) coordinates the development and maintenance of
accessible public information through the Internet, social media and
other applicable channels; (11) supervises and manages a comprehensive
records management activity in accordance with National Archives and
Records Administration standards and CERCLA legislative requirements;
(12) provides training and technical assistance in the areas of health
communication, risk communication, social marketing, and public
affairs; (13) provides editorial services, including writing, editing,
and technical editing; (14) supervises and manages OC activities,
programs, and staff; (15) serves as liaison to internal and external
groups to advance the agency's mission; (16) collaborates with the CDC
Office of the Associate Director for Communication on media relations,
electronic communication, health media production, and brand management
activities; and (17) collaborates with CDC Centers/Institute/Offices in
the development of marketing communications targeted to populations
that would benefit from a cross-functional approach.
Dated: September 27, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-25221 Filed 10-8-10; 8:45 am]
BILLING CODE 4160-70-M
